Skip to main content
Clinical Trials/ITMCTR2100004510
ITMCTR2100004510
Recruiting
Phase 1

Based on fNIRS to explore the brain effect mechanism of Jing-point health exercises in the treatment of mild cognitive impairment

Tianjin University of Traditional Chinese Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Mild cognitive impairment
Sponsor
Tianjin University of Traditional Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Tianjin University of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • (1\) It accords with the diagnostic criteria of amnesia mild cognitive impairment;
  • (2\) Aged 55 to 75 years;
  • (3\) The chief complaint includes subjective sensory memory loss;
  • (4\) Objective examination showed memory loss and cognitive changes: the MoCA score was less than 26 (180\.25\). If the length of education was less than 12 years, the score would be added to the score of; MMSE (24,29\). The AVLT score was below 1\.5 standard deviations of age and education (55\-59 \<\= 4, 60\-69 \<\= 3, 70\-75 \<\= 2\);
  • (5\) The (CDR) score of the Clinical dementia rating scale was 0\.5 or the (GDS) score of the Comprehensive decline scale was 2 or 3, which did not meet the diagnostic criteria of dementia in the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders revised version IV (DSM\-IV\-R);
  • (6\) Activities of daily living scale (ADL) evaluation of activities of daily living is basically normal, independent living function is complete;
  • (7\) Did not take drugs to improve mental or motor disorders;
  • (8\) The subjects are primary school grade 6 or above, have the ability to complete the cognitive ability test and other tests stipulated in the program, and have the ability and time to complete the prescribed aerobics training;
  • (9\) Did not engage in regular exercise in the past three months (that is, at least 3 times a week, each time at least 20 minutes of various forms of regular exercise);
  • (10\) The subjects informed consent and volunteered to participate.

Exclusion Criteria

  • (1\) The Hachinsk ischemia index scale (HIS) score was \> 4;
  • (2\) Other causes of cognitive decline: cerebrovascular disease, central nervous system infection, g \- disease, huntington's chorea, DLB and Parkinson's disease, traumatic brain dementia, other physical and chemical factors (such as drugs, alcohol, CO), important body disease (hepatic encephalopathy, pulmonary encephalopathy), intracranial space\-occupying lesions (a subdural hematoma, brain tumor), the endocrine system lesion (thyroid disease, parathyroid disease), and vitamins or other cognitive causes of dementia;
  • (3\) A history of neurological diseases (including stroke, optic neuromyelitis, epilepsy, Parkinson's disease, etc.);
  • (4\) Psychiatric patients, dSM\-IV criteria for schizophrenia or other psychiatric disorders, bipolar affective disorder, major depression or delirium;
  • (Hamilton anxiety scale (HAMA) assessment, scoring \> 6;
  • Hamilton depression scale (HAMD) had 21 evaluations, scoring \> 8 points.
  • (5\) Abnormal laboratory indicators: liver function (ALT or AST) is 1\.5 times higher than the upper limit of the normal range; Cr is 1\.5 times higher than the upper limit of the normal range; anemia is moderate or above; fasting blood glucose value is 1\.5 times higher than the upper limit of the normal range;
  • (6\) Unstable or severe heart, lung, liver, kidney, hematopoietic diseases;
  • Severe diseases with poor prognosis, such as malignant tumors, have been informed;
  • (7\) The presence of uncorrectable visual and auditory disorders can not complete the scale and other relevant tests;

Outcomes

Primary Outcomes

Not specified

Similar Trials